Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sleep to Lower Elevated Blood Pressure (SLEPT)

This study has been completed.
Sponsor:
Collaborator:
Health Research Board, Ireland
Information provided by (Responsible Party):
Dr. Emer McGrath, University College Hospital Galway
ClinicalTrials.gov Identifier:
NCT01809821
First received: March 8, 2013
Last updated: September 1, 2014
Last verified: September 2014
  Purpose

Sleep is an essential component of good physical and mental health. Previous studies have reported that poor quality sleep is associated with an increased risk of hypertension, stroke and cardiovascular disease (CVD). Hypertension is the most common and important risk factor for CVD, and even modest reductions in blood pressure result in significant reductions in stroke and myocardial infarction. In this randomised trial, the investigators aim to evaluate whether a simple, multi-component, online sleep intervention reduces blood pressure in patients with essential hypertension.


Condition Intervention
Hypertension
Sleep Disorders
Insomnia
Cardiovascular Diseases
Behavioral: Online Sleep Education

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Sleep to Lower Elevated Blood Pressure: A Randomised Controlled Trial

Resource links provided by NLM:


Further study details as provided by University College Hospital Galway:

Primary Outcome Measures:
  • Systolic Blood Pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    To determine if the addition of a multi-component, online, sleep intervention to usual care (standard CV risk factor education), results in a greater reduction in mean 24-hr systolic blood pressure in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8-week period.


Secondary Outcome Measures:
  • Diastolic Outcome Measure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a greater reduction in mean 24-hr diastolic blood pressure in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8-week period?

  • Sleep efficiency [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Change in proportion of participants with sleep efficacy ≥ 85% at 8 weeks

  • Sleep onset latency [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Change in proportion of participants with sleep onset latency ≤ 30 minutes at 8 weeks

  • PSQI [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Change in proportion of participants with Pittsburgh Sleep Quality Index (PSQI) score <5 over 8 weeks

  • SCI [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Change in proportion of participants with sleep condition indicator (SCI) score ≤5.9 at 8 weeks

  • ISI [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Change in proportion of participants with Insomnia Severity index (ISI) score ≥15 at 8 weeks


Other Outcome Measures:
  • Body Mass Index [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in body mass index in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Plasma lipoproteins [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in plasma lipids in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Plasma HbA1c [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in plasma HbA1c in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • eGFR [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in eGFR in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Insomnia Severity Index [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in Insomnia Severity Index Score in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Sleep Condition Indicator Score [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in Sleep Condition Indicator Score in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Pittsburgh Sleep Quality Index [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in Pittsburgh Sleep Quality Index in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Mean number of cigarettes smoked [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in mean number of cigarettes smoked in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Sleep onset latency [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in sleep onset latency in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Wake time to sleep onset [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in wake time to sleep onset in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Sleep efficiency [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in sleep efficiency in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Beck Depression Inventory score [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in Beck Depression Inventory score in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Beck Anxiety Inventory score [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with greater improvements in Beck Anxiety Inventory score in patients with hypertension and poor sleep quality, compared to usual care alone, over an 8 week period?

  • Smoking status [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in smoking status compared to usual care alone, over an 8 week period?

  • Diastolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in daytime (peak and mean) diastolic blood pressure , compared to usual care alone, over an 8 week period?

  • Systolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in daytime (peak and mean) systolic blood pressure , compared to usual care alone, over an 8 week period?

  • Total Sleep Time [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in Total Sleep Time , compared to usual care alone, over an 8 week period?

  • Diastolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in nighttime (peak and mean) diastolic blood pressure , compared to usual care alone, over an 8 week period?

  • Systolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the addition of a multi-component online sleep intervention to usual care (standard CV risk factor education), associated with a change in nighttime (peak and mean) systolic blood pressure , compared to usual care alone, over an 8 week period?

  • Systolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Is the level of adherence to a multi-component online sleep intervention associated with a change in mean 24-hour SBP over 8 weeks

  • Systolic blood pressure [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    To determine if concomitant use of antihypertensive medication influences the change in mean 24-hour SBP over 8 weeks .


Enrollment: 134
Study Start Date: May 2013
Study Completion Date: June 2014
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Online Sleep Education
The sleep intervention is a multi-component online intervention consisting of sleep information and sleep hygiene education, along with behavioural and cognitive components.
Behavioral: Online Sleep Education
No Intervention: Usual CV care
Specialist nurses will administer the CV risk factor education intervention to participants in small groups over one hour.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Signed written informed consent
  • ≥18 years on entry to study
  • Average automated Systolic Blood Pressure (SBP) monitor readings between 130 - 160 mmHg with average automated Diastolic Blood Pressure(DBP) monitor readings <110 mmHg on three occasions, measured in a valid standardized manner while seated, or average Ambulatory Blood Pressure Monitor (ABPM) SBP reading between 130-160 mmHg with average DBP reading <110 mmHg.
  • Self-reported difficulty getting to sleep (defined as usually taking more than 30 mins to get to sleep), and/or staying asleep (usually waking up more than once per night) for at least 3 months duration
  • Internet access and self-reported competency in using the internet

Exclusion Criteria:

  • Receiving > 2 antihypertensive medications, or recent change in antihypertensive medications (within previous 2 months) or planned change in antihypertensive medication in next 8 weeks
  • Previous history of myocardial infarction, ischaemic stroke or transient ischaemic attack
  • Previous history of congestive heart failure
  • History of dialysis for chronic renal impairment or evidence of chronic kidney disease (eGFR <60 or albuminuria).
  • Known history of diabetes mellitus
  • Current ongoing sleep hygiene education or sleep related cognitive behavioural therapy
  • Ongoing involvement in night shift work
  • History of obstructive sleep apnoea (OSA) and previously received or currently receiving treatment for OSA (patients with a history of untreated OSA are eligible for inclusion).
  • Known history of sleep disorders (i.e. narcolepsy; hypersomnias; parasomnias such as sleep walking, night terrors, recurring nightmares; periodic limb movements/restless leg syndrome; circadian rhythm sleep disorder)
  • Unable to follow educational advice in the opinion of the clinician
  • Baby or young children at home that wake during the night
  • History of bipolar affective disorder
  • History of psychosis
  • History of major depression (defined as depression requiring hospitalization in the past or visit to psychiatry outpatient clinic in the past 3 months)
  • Unstable depression (unstable will be defined as changes in antidepressant medications within the last 3 months - i.e. start, stop or change in dose.)
  • Unstable anxiety disorders/panic attacks (unstable will be defined as changes in medications within the last 3 months - i.e. start, stop or change in dose.)
  • Ongoing substance or alcohol abuse
  • Planned surgery or hospitalization over the next 8 weeks (i.e. during the trial)
  • Incapacitating pain or illness or other medical condition in which, in the opinion of the clinician, the sleep intervention is unlikely to be effective.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01809821

Locations
Ireland
HRB Clinical Research Facility Galway
Galway, Ireland
Sponsors and Collaborators
University College Hospital Galway
Health Research Board, Ireland
Investigators
Principal Investigator: Martin J O'Donnell, MB PhD National University of Ireland Galway
  More Information

No publications provided by University College Hospital Galway

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. Emer McGrath, Dr.Emer McGrath, University College Hospital Galway
ClinicalTrials.gov Identifier: NCT01809821     History of Changes
Other Study ID Numbers: HRBCRFG-150213-EMG
Study First Received: March 8, 2013
Last Updated: September 1, 2014
Health Authority: Ireland: Research Ethics Committee

Keywords provided by University College Hospital Galway:
Hypertension
Sleep Disorders
Insomnia
Cardiovascular Diseases
Internet treatment

Additional relevant MeSH terms:
Cardiovascular Diseases
Hypertension
Parasomnias
Sleep Disorders
Mental Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Vascular Diseases

ClinicalTrials.gov processed this record on November 25, 2014